Status: Recruiting
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
This is a single-arm single center study to prospectively evaluate the safety and efficacy of ultra-fraction radiotherapy bridging CAR-T therapy in relapsed/refractory diffuse large b cell lymphoma
Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peking Union Medical College HospitalUpdated: Mar 24, 2026Locations: 1
Eligibility criteria
Over than 18 years old [+5]
Prior radiation therapy within 1 year of infusion [+6]